CSIMarket
 
Adma Biologics Inc   (ADMA)
 

Respectable revenue fueled to reduce losess, at Adma Biologics Inc amid the financial fourth quarter of 2022

Adma Biologics Inc reported fourth quarter of 2022 operating deficit of $-6.058542 million


Published Mar 24 2023
CSIMarket Team / CSIMarket.com


Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Respectable Revenue growth in the Dec 31 2022 report, by 89.447 % to $49.98 million fueled to cut losses to $-0.05 per share, from $-0.09 in corresponding reporting season a year before.

Conflicting to the Q3 revenue improved by 21.639 % from $41.09 million and EPS improved from $-0.08 per share.


In the fiscal span closing December 31 2022 Adma Biologics Inc reported net loss of $-12.232 million, instead of deficit of $-16.649 million in the corresponding reporting season a year ago.

What's more important, the company claimed as well a shortfall of $-65.90 million and for the financial year 2022, revenue of $154.08 million.

Biotechnology & Pharmaceuticals The company has decreased it's loss per share to $-0.33 from $-0.51 in the previous fiscal year, while revenue surged by 90.36 % from $80.94 million a year before.

Adma Biologics Inc is expected to report next financial earnings on May 10, 2023.



Adma Biologics Inc's Dividend Comparisons

Adma Biologics Inc's Revenue Growth



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com